ScripsAmerica Inc. (SCRCQ)

[ed longstock]

That a company called Global Pharma Hub has the licensing and distribution rights to RapiMed. Most likely, in my opinion, Global Pharma has partnered with a Hong Kong domiciled importer so RapiMed can be imported. I imagine Forbes, the original China player in this mix, is associated with or arranged the importer.

I found Global Pharma's website: www.globalpharmahub.com

Appears they specialize in taking medicines and medical products and packaging them for licensing, marketing and distribution into new foreign markets. The jury is out on their abilities, but Scrips signed with them so there must be confidence in performance capabilities.

We should know shortly regarding RapiMed registration approval. If it is approved, that is major, monumental news and the door officially opening to the China market.